Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9635700Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Microbiology & Immunology
NIH Funding · FY2025
Linked Award Amount
$3M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#3,395
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Roza Insafetdinovna Nurieva as a PI. Multi-PI records show the full award amount for context.
- 1R01AI183604-01A1R01Role of GRAIL in B cell tolerance and B-cell mediated inflammation$2.6Maward amount
- 5R01CA284684-03R01Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors$370.6Kaward amount
Award organization
Organizations that administered FY2025 awards listing Roza Insafetdinovna Nurieva as a PI.
FY2025 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUT MD Anderson Cancer Center
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #3395
- 2025Entered Top 25% NationallyRanked #3395
- 2025R01 Grant Holder